ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
6,086.37
0.61%
Dow Jones
44,156.73
0.30%
US Dollar vs MXN
20.5011
-0.01%
Brent Oil
77.955
-0.49%
Bitcoin
102,336.97
-1.25%
Pepperstone
Advertisement
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NYSE

  6. Bausch plus Lomb Corporation (BLCO) Cotización

Bausch plus Lomb Corporation

Bausch plus Lomb Corporation (BLCO)

Bausch and Lomb Corporation
Bausch and Lomb Corporation
17.07
-0.11
(-0.64%)
Cerrado 23 Enero 3:00PM
Delayed by 15 minutes
17.06
-0.01
(-0.06%)
Fuera de horario: 6:59PM
Delayed by 15 minutes

Herramientas de nivel profesional para inversores individuales.

Premium

Estadísticas y detalles clave

Último Precio
17.07
Postura de Compra
-
Postura de Venta
-
Volume Operado de la Acción
1,091,513
16.92 Rango del Día 17.335
13.16 Rango de 52 semanas 21.69
Capitalización de Mercado [m]
6.011B
Precio Anterior
17.18
Precio de Apertura
17.22
Hora
5
@
17.07
Última hora de negociación
Volumen financiero
US$ 18,765,357
Precio Promedio Ponderado
17.1921
Volumen promedio (3 m)
472,917
Acciones en circulación
352,164,025
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-33.10
Beneficio por acción (BPA)
-0.74
turnover
4.15B
Beneficio neto
-260M

Acerca de Bausch plus Lomb Corporation

Bausch & Lomb, headquartered in Laval, Quebec, Canada, is the fourth-largest vision care company by sales in the United States and the market leader in consumer vision care in India and China. The firm, which was previously a subsidiary under parent company Bausch Health, was spun off to become a pu... Bausch & Lomb, headquartered in Laval, Quebec, Canada, is the fourth-largest vision care company by sales in the United States and the market leader in consumer vision care in India and China. The firm, which was previously a subsidiary under parent company Bausch Health, was spun off to become a public company once again in May 2022. The firm reports in three segments-vision care and consumer (60% of revenue), surgical (20%), and ophthalmic pharmaceuticals (20%). The company is geographically diversified, with 48% of revenue in the Americas, 30% from EMEA, and 22% from Asia-Pacific countries. Mostrar más

Sector
Offices Of Optometrists
Industria
Offices Of Optometrists
Sede
Toronto, Ontario, Can
Fundado
-
Bausch plus Lomb Corporation is listed in the Offices Of Optometrists sector of the New York Stock Exchange with ticker BLCO. The last closing price for Bausch plus Lomb was US$17.18. Over the last year, Bausch plus Lomb shares have traded in a share price range of US$ 13.16 to US$ 21.69.

Bausch plus Lomb currently has 352,164,025 shares in issue. The market capitalisation of Bausch plus Lomb is US$6.05 billion. Bausch plus Lomb has a price to earnings ratio (PE ratio) of -33.10.

BLCO Últimas noticias

Más noticias

Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2024 Financial Results on February 19

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its fourth-quarter and full-year 2024 financial...

19 horas hace
Business Wire

Bausch + Lomb Bolsters Pipeline with Acquisition of Whitecap Biosciences

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced an affiliate has acquired Whitecap...

13 Enero 2025
Business Wire

Bausch + Lomb Launches enVista Aspire™ Intermediate Optimized Monofocal and Toric Intraocular Lenses in the European Union

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the commercial launch of the enVista Aspire...

13 Enero 2025
Business Wire

Bausch + Lomb and Glaucoma Research Foundation Launch Second Annual “Faces of Glaucoma” Campaign and Fundraising Challenge

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, and Glaucoma Research Foundation (GRF), a national nonprofit...

07 Enero 2025
Business Wire

Bausch + Lomb to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Chairman and CEO Brent Saunders, Chief...

02 Enero 2025
Business Wire

Form 4 - Statement of changes in beneficial ownership of securities

26 Diciembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

26 Diciembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

26 Diciembre 2024
Edgar (US Regulatory)

Bausch + Lomb Responds to Rumors of a Potential Sale

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, issued the following statement in response to a request from...

12 Diciembre 2024
Business Wire

Bausch + Lomb Acquires Elios Vision, Significantly Enhances Glaucoma Treatment Capabilities

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that an affiliate has acquired Elios Vision...

11 Diciembre 2024
Business Wire
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.47-2.6795895096917.5417.5716.9864674617.32218641CS
4-0.79-4.4232922732417.8618.553416.75545355717.60481557CS
12-3.73-17.932692307720.820.9416.75547291718.82679767CS
26-0.23-1.3294797687917.321.6914.0565159218.24220659CS
522.5417.481073640714.5321.6913.1654706317.03451346CS
156-1.43-7.7297297297318.521.9512.260682516.71281345CS
260-1.43-7.7297297297318.521.9512.260682516.71281345CS

BLCO - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Bausch plus Lomb?
El precio actual de las acciones de Bausch plus Lomb es US$ 17.07
¿Cuántas acciones de Bausch plus Lomb están en circulación?
Bausch plus Lomb tiene 352,164,025 acciones en circulación
¿Cuál es la capitalización de mercado de Bausch plus Lomb?
La capitalización de mercado de Bausch plus Lomb es USD 6.05B
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Bausch plus Lomb?
Bausch plus Lomb ha negociado en un rango de US$ 13.16 a US$ 21.69 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Bausch plus Lomb?
El ratio precio/beneficio de Bausch plus Lomb es -33.1
¿Cuál es el ratio de efectivo a ventas de Bausch plus Lomb?
El ratio de efectivo a ventas de Bausch plus Lomb es 2.08
¿Cuál es la moneda de reporte de Bausch plus Lomb?
Bausch plus Lomb presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Bausch plus Lomb?
El último ingresos anual de Bausch plus Lomb es USD 4.15B
¿Cuál es el último beneficio anual de Bausch plus Lomb?
El último beneficio anual de Bausch plus Lomb es USD -260M
¿Cuál es la dirección registrada de Bausch plus Lomb?
La dirección registrada de Bausch plus Lomb es 520 APPLEWOOD CRESCENT, VAUGAN, ONTARIO, L4K 4B4, TORONTO, ONTARIO, L4K 4B4
¿En qué sector industrial opera Bausch plus Lomb?
Bausch plus Lomb opera en el sector OFFICES OF OPTOMETRISTS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
STGSunlands Technology Group
US$ 6.86
(23.92%)
40.11k
ENFYEnlightify Inc
US$ 0.95
(15.66%)
259.84k
BYONBeyond Inc
US$ 6.93
(15.50%)
5.19M
NOTEFiscaNote Holdings Inc
US$ 1.575
(14.96%)
7.79M
AZULAzul SA
US$ 2.48
(13.24%)
2.52M
VNCEVince Holding Corp
US$ 2.32
(-21.36%)
3.69M
WKWorkiva Inc
US$ 98.85
(-13.32%)
2.2M
PDXPIMCO Dynamic Income Strategy Fund
US$ 27.55
(-13.26%)
748.14k
LANVLanvin Group Holdings Limited
US$ 2.00
(-13.04%)
107.88k
VOCVoc Energy Trust
US$ 3.79
(-11.86%)
453.88k
QBTSD Wave Quantum Inc
US$ 6.2499
(-0.64%)
115.1M
FFord Motor Company
US$ 10.03
(-3.84%)
59.2M
VALEVale SA
US$ 8.87
(-1.22%)
52.55M
NUNu Holdings Ltd
US$ 11.995
(4.49%)
52.54M
BBDBanco Bradesco SA
US$ 1.9599
(-0.01%)
42.76M

BLCO Discussion

Ver más
Zilla Zilla 1 mes hace
The end of 2024 is near but the spin/sale of BLCO is not. lol Well Blackstone might have gotten cold feet and invested elsewhere which is fine as the offer was probably too low. Maybe it gets settled around the 3 year IPO mark in May but who knows. Only 1.08 million short and 10.3% inst owned. Market cap of 6.53 billion @ 18.55 a share.
BHC 7.65 and chart looking like a downer below the 20, 50 & 200 DMA's YIKES...
👍️0
Zilla Zilla 9 meses hace
Good ER but stock dived down, bounced up and down again...Hit 13.64 and closed 13.74
So that golden cross might be off the table unless it pops tomorrow if BHC doesn't distribute in 2024...
👍️0
Zilla Zilla 9 meses hace
Almost another year later and 88.7% of BLCO is still with BHC almost 2 years after the IPO just before the ER...
Currently BLCO is 14.79 with less than 5% short interest...10.5% Inst owned...
BHC is @ 8.71 72% inst/owned about 12% short interest...
Norwich lost in court recently and BHC had hit 11.46 a little before the verdict on a quick POP and it's been dropping ever since. Didn't break below the 200DMA of 8.30 but tested the 8.50's often...
👍️0
Zilla Zilla 9 meses hace
BLCO @ 14.79 with ER next week...
200DMA 16.53
50DMA 15.89
Golden Cross may be heading our way...If the ER sends us up and BHC doesn't announce a distribution...
👍️0
Zilla Zilla 11 meses hace
Good ER and more than a buck higher open it looks like. I sold too soon as always and also I sold a 100 calls so that's about 20,000 I would have gotten more had I held 1 day longer. Still got my 'core' of calls that are good til there end of the year but these results are really good. Stock should be fine moving forward until BHC shareholders get the BLCO shares and then it will probably sell off but recover and make new highs at some point. =)
👍️0
Zilla Zilla 11 meses hace
Sold all 10,000 BLCO above 14.50 just a few cents higher than my cost after flipping so many times. Have good chunk of calls both ITM and not. Just felt I had WAY too much in one stock with all these M&A deals it seems like a 'top' is incoming. So as of now I'm about 20% in calls and 80% in cash... Was 15% cash and 85% invested this morning. Good luck tomorrow and the chart looks really good to run to 17's in the coming weeks as long as tomorrow doesn't surprise to the downside.
👍️0
Zilla Zilla 11 meses hace
Yesterday BLCO hit 14.66. I sold a good chunk @ 14.50 even though I wanted to keep it but got it back today @14
Chart looking like a nice set up into and after earnings next week. We shall see but I've flipped enough times and lowered my average so I'm feeling good. If it tanks on news of BHC shareholders getting BLCO stock my BHC will rise/rocket and I can either hold that for the BLCO shares or trade them accordingly being I already have BLCO shares. Or buy the shares back into BHC and that works too. Stock too cheap down here under 15
👍️0
Zilla Zilla 12 meses hace
Today BLCO made new 52 week low of 13.85 currently at 14 with BHC at 8....Something has changed between these two stocks. lol
I still think both are undervalued and stuck together. Needed to either give BHC shareholders the 80% BLCO shares or...Reverse Merge or buy back BLCO. At 14 for BLCO they could gobble it right back up and the spin at least let them pay down some debt when distressed the past year and a half.
BLCO at 14 feels like a spin of the 50.1% is coming this year but who knows...ER's should be this month and hopefully BOTH stocks rise up to new 52 week highs but you never know. lol
👍️0
Zilla Zilla 2 años hace
Today BLCO buys XIIDRA from NVS and makes new all time high of 21.95
BHC went up to 8.22 and closed at 8
So the future 'growth' will be the BLCO asset and getting 80% of the company in BHC shareholders hands. BHC is 7% short interest as BLCO is over 17 and stock is just above 20...
I think both are undervalued
👍️0
Zilla Zilla 2 años hace
1 year later not so much. lol Though 88.7% of BLCO is still with BHC over a year after the IPO...BS!
Currently about 18.50 for BLCO with 19% short interest and almost 13% Inst/own...
BHC I use to see under 10% short interest but I double taked when I saw 37.22% short interest (as of 5/31/23 and 66% Inst/own trading at 7.19 today. WTF?!? That's some SERIOUS Shorts...Also seems kind of fishy with the 5/17 judge ruling in BHC favor sending the stock from 6 to 9 in days...Only to have Norwich sue the FDA to overrule the courts news on 6/6/23 with the stock breaking below 8 the day before and then breaking below 7... I think a lawsuit and an investigation is in order.
👍️0
Zilla Zilla 3 años hace
Well now we will see what B&L can do away from BHC/VRX
👍️0
weedtrader420 weedtrader420 3 años hace
BLCO$ Cross Eyed Mary
👍️0
weedtrader420 weedtrader420 3 años hace
BLCO$
👍️0

Su Consulta Reciente

NYSE
BLCO
Bausch plus Lomb
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados